Cathepsin B (Homo sapiens)

From Cysteinome
Revision as of 18:30, 31 July 2019 by Wu3857 (talk | contribs) (Created page with "{| align="left" | __TOC__ |} {{#invoke:InfoboxforTarget|run|CSPB, CTSB|[https://www.uniprot.org/uniprot/P07858 P07858]|Homo sapiens|Cys108|[http://pfam.xfam.org/family/PF0...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Basic Information
Short Name CSPB, CTSB
UNP ID P07858
Organism Homo sapiens
Cys Site Cys108
Family/Domain Peptidase C1 family
Known Ligand Ligand list
Function Type Protease

Summary

Protein Function

Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis. (From Uniprot)
Cathepsin B (CatB) is an enzymatic protein belonging to the peptidase (or protease) families. In humans, it is coded by the CTSB gene. The protein encoded by this gene is a lysosomal cysteine protease composed of a dimer of disulfide-linked heavy and light chains, both produced from a single protein precursor. It is a member of the peptidase C1 family. At least five transcript variants encoding the same protein have been found for this gene. (From Wikipedia)

Cys Function & Property

Cys108 is one of the active sites of Cathepsin B, which is very close to His278 and Asn298 in space. These three residues formed a typical catalytic triad motif.

  • Hydrophobic property:
509-hydro.png
  • SASA:
Cys108: 11.819 A^2

Protein Sequence

MWQLWASLCC LLVLANARSR PSFHPLSDEL VNYVNKRNTT WQAGHNFYNV
DMSYLKRLCG TFLGGPKPPQ RVMFTEDLKL PASFDAREQW PQCPTIKEIR
DQGSCGSCWA FGAVEAISDR ICIHTNAHVS VEVSAEDLLT CCGSMCGDGC
NGGYPAEAWN FWTRKGLVSG GLYESHVGCR PYSIPPCEHH VNGSRPPCTG
EGDTPKCSKI CEPGYSPTYK QDKHYGYNSY SVSNSEKDIM AEIYKNGPVE
GAFSVYSDFL LYKSGVYQHV TGEMMGGHAI RILGWGVENG TPYWLVANSW
NTDWGDNGFF KILRGQDHCG IESEVVAGIP RTDQYWEKI

Structural Information

  • Known structure with covalent ligand:
1CSB, 2IPP, 1GMY
  • Protein structure:
509.png

Related Pathway

Experimental Evidence

Crystallography, MALDI-TOF-MS, Homologous Analysis of Sequence, Enzymatic Assay, Isotope Labeling

Reference

  1. Turk D, Podobnik M, Popovic T, et al. Crystal structure of cathepsin B inhibited with CA030 at 2.0-. ANG. resolution: A basis for the design of specific epoxysuccinyl inhibitors[J]. Biochemistry, 1995, 34(14): 4791-4797. 7718586
  2. Respondek T, Garner R N, Herroon M K, et al. Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with RuII(bpy)2[J]. Journal of the American Chemical Society, 2011, 133(43): 17164-17167. 21973207
  3. Méthot N, Rubin J, Guay D, et al. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing[J]. Journal of Biological Chemistry, 2007, 282(29): 20836-20846. 17535802
  4. Dana D, Davalos A R, De S, et al. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins[J]. Bioorganic & medicinal chemistry, 2013, 21(11): 2975-2987. 23623677
  5. Greenspan P D, Clark K L, Tommasi R A, et al. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design[J]. Journal of medicinal chemistry, 2001, 44(26): 4524-4534. 11741472
  6. Wisastra R, Ghizzoni M, Maarsingh H, et al. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF[J]. Organic & biomolecular chemistry, 2011, 9(6): 1817-1822. 21267493
  7. Falgueyret J P, Black W C, Cromlish W, et al. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells[J]. Analytical biochemistry, 2004, 335(2): 218-227. 15556560